# Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains

> **NCT02855229** · — · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 222 (actual)

## Conditions studied

- Translational Electrophysiology

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT02855229
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-15
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02855229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02855229, "Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02855229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*